Viral genomes in the pericardial fluid and in peri- and epicardial biopsies from a German cohort of patients with large to moderate pericardial effusions
Tóm tắt
The aetiology of pericardial effusion has been generally assessed by clinical work-up only, which leaves a large cohort of patients with “idiopathic” effusions virtually undiagnosed. In accordance with the ESC guidelines, this contribution intends to change this attitude. After therapeutic or diagnostic pericardiocentesis of 259 patients with large to moderate pericardial effusions, pericardial fluid, epicardial and pericardial biopsies, and blood samples were analysed by PCR for cardiotropic microbial agents. Cytology, histology, immunohistology of tissue and fluids and laboratory tests were performed. Of the 259 patients, 35 % suffered from an autoreactive aetiology, 28 % suffered from a malignant and 14 % from an infectious cause. Investigating all samples by PCR, we identified viral genomes in 51 (19.7 %) patients, parvovirus B19 (B19 V) being identified in 25 and Epstein–Barr virus (EBV) in 19 cases. In patients with a sole infectious aetiology (n = 36), B19 V was detected in 21 and EBV in 10 cases. When differentiating with regard to the material investigated for the presence of cardiotropic viruses, parvovirus B19 was most often detected in the epicardium and EBV was most frequently detected in the pericardial fluid independent from the final diagnostic categorisation. Bacterial cultures including tests for tuberculosis were all negative. Molecular techniques improve sensitivity, specificity and diagnostic accuracy for the underlying aetiology in pericarditis patients with effusion. The identification of specific viral signatures will help to understand pathogenetic mechanisms in pericarditis and allow to tailor an adequate therapy beyond antiphlogistic treatment.
Tài liệu tham khảo
Troughton RW, Asher CR, Klein AL (2004) Pericarditis. Lancet 363:717–727
Spodick DH (1997) The pericardium: a comprehensive textbook, 1st edn. Marcel Dekker, New York, p 260
LeWinter MM, Tischler MD (2012) Pericardial disease. In: Braunwald E, Bonow RO, Mann DL, Zipes D, Libby P (eds) Heart disease: a textbook of cardiovascular medicine, 9th edn. W.B. Saunders Company, Philadelphia PA, pp 1651–1671
Spodick DH (2001) Pericardial disease. In: Braunwald E, Zipes D, Libby P (eds) Heart disease: a textbook of cardiovascular medicine. W.B. Saunders Company, New York
Maisch B, Ristic A, Seferovic P (2011) Tsang TSM. Interventional Pericardiology, Springer Medizin, Verlag Heidelberg
Corey GR, Campbell PT, Van Trigt P, Kenney RT, O’Connor CM, Sheikh KH, Kisslo JA, Wall TC (1993) Etiology of large pericardial effusions. Am J Med 95(2):209
Mayosi BM, Burgess LJ, Doubell AF (2005) Tuberculous pericarditis. Circulation 112:3608–3616
Sagrista-Sauleda J, Mercé J, Permanyer-Miralda G, Soler–Soler J (2000) Clinical clues to the causes of large pericardial effusions. Am J Med 109(2):95–101
Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH (2004) Task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary. Eur Heart J 25(7):587–610
Horowitz MDS, Schultz CS, Stinson EB, Harrison DC, Popp RL (1974) Sensitivity and specificity of echocardiographic diagnosis in pericardial effusion. Circulation 50:239–245
Maisch B, Ristić AD (2003) Practical aspects of the management of pericardial disease. Heart 89(9):1096–1103
Maisch B, Drude L (1991) Pericardioscopy—a new diagnostic tool in inflammatory diseases of the pericardium. Eur Heart J 12(Suppl B):2–7
Maisch B, Ristic AD, Pankuweit S (2002) Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone; the way to avoid side effects of systemic corticosteroid therapy. Eur Heart J 23:1503–1508
Maisch B, Ristic AD, Pankuweit S, Neubauer A, Moll R (2002) Neoplastic pericardial effusion. efficacy and safety of intrapericardial treatment with cisplatin. Eur Heart J 23(20):1625–1631
Pankuweit S, Portig I, Eckhardt H, Crombach M, Hufnagel G, Maisch B (2000) Prevalence of viral genome in endomyocardial biopsies from patients with inflammatory heart muscle disease. Herz 25(3):221–226
Pankuweit S, Moll R, Baantrup U, Portig I, Hufnagel G, Maisch B (2003) Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. Hum Pathol 34:497–500
Pankuweit S, Wädlich A, Meyer E, Portig I, Hufnagel G, Maisch B (2000) Cytokine activation in pericardial fluids in different forms of pericarditis. Herz 25(8):748–754
Dalla Pozza R, Hartl D, Bechtold S, Urschel S, Kozlik-Feldmann R, Pankuweit S, Belohradsky B, Netz H (2007) Recurrent pericarditis in children: elevated cardiac autoantibodies. Clin Res Cardiol 96:1–8
Karatolios K, Pankuweit S, Goettsch C, Hofbauer LC, Timmesfeld N, Al-Fakhri N, Maisch B, Schoppet M (2012) Osteoprotegerin (OPG) and TNF-related apoptosis-inducing ligand (TRAIL) levels in malignant and benign pericardial effusions. Clin Biochem 45(3):237–242
Karatolios K, Pankuweit S, Moosdorf RG, Maisch B (2012) Vascular endothelial growth factor in malignant and benign pericardial effusion. Clin Cardiol 35(6):377–378
Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 World Health Organization/International society and federation of cardiology task force on the definition and classification of cardiomyopathies. Circulation 93:841–842
Maisch B, Bültman B, Factor S, Gröne HJ, Hufnagel, Kawamura K, Kühl U, Olsen EJ, Pankuweit S, Virmani R (1999) World Heart Federation consensus conference’s definition of inflammatory cardiomyopathy (myocarditis): report from two expert committees on histology and viral cardiomyopathy. Heartbeat 4:3–4
Maisch B, Portig I, Ristic A, Hufnagel G, Pankuweit S (2000) Definition of inflammatory cardiomyopathy (myocarditis): on the way to consensus. Herz 25(3):200–209
Imazio M, Mayosi BM, Brucato A, Markel G, Trinchero R, Spodick DH, Adler Y (2010) Triage and management of pericardial effusion. J Cardiovasc Med (Hagerstown) 11:928–935
Imazio M (2012) Contemporary management of pericardial diseases. Curr Opin Cardiol 27(3):308–317
Sagrista`-Sauleda J, Merce′ AS, Soler-Soler J (2011) Diagnosis and management of pericardial effusion. World J Cardiol 3:135–143
Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y (2010) Controversial issues in the management of pericardial diseases. Circulation 121:916–928
Imazio M (2011) Evaluation and management of pericarditis. Expert Rev Cardiovasc Ther 9(9):1221–1233
Mahfoud F, Gärtner B, Kindermann M, Ukena C, Gadomski K, Klingel K, Kandolf R, Böhm M, Kindermann I (2011) Virus serology in patients with suspected myocarditis: utility or futility? Eur Heart J 32(7):897–903
Rohayem J, Dinger J, Fischer R, Klingel K, Kandolf R, Rethwilm A (2001) Fatal myocarditis associated with acute parvovirus B19 and human herpesvirus 6 coinfection. J Clin Microbiol 39:4585–4587
Heegaard ED, Eiskjaer H, Baandrup U, Hornsleth A (1998) Case report: parvovirus B19 infection associated with myocarditis following adult cardiac transplantation. Scand J Infect Dis 30:607–610
Chia JKS (1996) Myopericarditis due to parvovirus B19 in an adult. Clin Infect Dis 23:200–201
Zafrir B, Aviv A, Reichman N, Flatau E (2005) Epstein-Barr virus associated pericarditis and pericardial effusion: case report and diagnostic aspects. Eur J Intern Med 16:528–530
Roubille F, Gahide G, Moore-Morris T, Granier M, Davy JM, Vernhet H, Piot C (2008) Epstein Barr virus (EBV) and acute myopericarditis in an immunocompetent patient: first demonstrated case and discussion. Intern Med 47(7):627–629
Mazouni C, Fina F, Romain S, Ouafik L, Bonnier P, Brandone J, Martin P (2011) Epstein-Barr virus as a marker of biological aggressiveness in breast cancer. Br J Cancer 18; 104(2):332–7